Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation


ONAT A., Can G., HERGENC G., YAZICI M., KARABULUT A., ALBAYRAK S.

INTERNATIONAL JOURNAL OF OBESITY, vol.31, no.7, pp.1119-1125, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 7
  • Publication Date: 2007
  • Doi Number: 10.1038/sj.ijo.0803552
  • Journal Name: INTERNATIONAL JOURNAL OF OBESITY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1119-1125
  • Istanbul University Affiliated: Yes

Abstract

Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.